Start your intake The Scientists and Company Behind Mounjaro Development Eli Lilly and Company, a pharmaceutical giant headquartered in Indianapolis, Indiana, led the development of Mounjaro through its research divisions focused on endocrinology and metabolic disease
The study was not randomized and the participants didn't know which extract they were taking
doi: 10.1111/cns.13694
Trial data generally shows: Mounjaro: 15-20% body weight reduction over 12-18 months Ozempic: 10-15% body weight reduction over a similar period If weight is the primary driver not just blood sugar Mounjaros dual-hormone mechanism gives it an edge for most patients
An Y, Cao CY, Sun SS, Wu HL, Zhang JZ, Li R, et al
Clinical Safety and Thyroid-Specific Considerations GLP-1 medications do not affect thyroid hormone absorption or levothyroxine efficacy directly